Histologic factors associated with nintedanib efficacy in patients with idiopathic pulmonary fibrosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histologic factors associated with nintedanib efficacy in patients with idiopathic pulmonary fibrosis
Authors
Keywords
Computed axial tomography, Pulmonary fibrosis, Histology, Specimen preparation and treatment, Biopsy, Multivariate analysis, Pneumonia, Surgical and invasive medical procedures
Journal
PLoS One
Volume 16, Issue 1, Pages e0245147
Publisher
Public Library of Science (PLoS)
Online
2021-01-08
DOI
10.1371/journal.pone.0245147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion
- (2019) Tomoyuki Fujisawa et al. EUROPEAN RESPIRATORY JOURNAL
- Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases
- (2018) Laurens J. De Sadeleer et al. CHEST
- Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis
- (2018) Keishi Sugino et al. Journal of Thoracic Disease
- Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach
- (2018) Anupam Kumar et al. Lancet Respiratory Medicine
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interobserver Agreement of Usual Interstitial Pneumonia Diagnosis Correlated With Patient Outcome
- (2016) Mikiko Hashisako et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Drug Treatment of Idiopathic Pulmonary Fibrosis
- (2016) William J. Canestaro et al. CHEST
- Pulmonary veno-occlusive disease
- (2016) David Montani et al. EUROPEAN RESPIRATORY JOURNAL
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
- (2016) Peter Goldstraw et al. Journal of Thoracic Oncology
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
- (2016) Luca Richeldi et al. RESPIRATORY MEDICINE
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comparing new treatments for idiopathic pulmonary fibrosis – a network meta-analysis
- (2015) Emma Loveman et al. BMC Pulmonary Medicine
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis
- (2007) M. Thomeer et al. EUROPEAN RESPIRATORY JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now